Thus, the inhibition of miR-34a by reducing Crtc2 activity in the liver could be beneficial in combating obesity and insulin resistance by promoting whole-body energy metabolism in an Fgf21-dependent manner. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.